
2.36BUSD
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
CA0717341071
CUSIP
09067J109
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
0.01
Book Value
-4.74
Dividend Share
-
Dividend Yield
-
Earnings Share
-3.24
Wall Street Target Price
7.50
EPS Estimate Current Year
4.52
EPS Estimate Next Year
4.29
EPS Estimate Current Quarter
1.007
EPS Estimate Next Quarter
1.191
Most Recent Quarter
-
Revenue TTM
10,853,000,192
Gross Profit TTM
7,794,999,808
EBITDA
3,908,000,000
Profit Margin
-10.12%
Return On Assets TTM
6.57%
Return On Equity TTM
43.64%
Revenue Per Share TTM
29.12
Qtly Revenue Growth YOY
12.70%
Diluted Eps TTM
-3.24
Qtly Earnings Growth YOY
70.40%
Trailing PE
0.00
Forward PE
1
Price Sales TTM
0.2385
Price Book MRQ
18.7773
Enterprise Value Revenue
1
Enterprise Value EBITDA
10
167.06
5.26%32.62
1.15%40.11
0.35%12.25
0.00%37.97
-7.73%95.35
-4.65%214.45
-1.93%5.00
-1.86%20.00
-0.69%44.75
-0.29%